Acta Pharmacologica Sinica 2005 Aug; 26 (8): 918-925; doi: 10.1111/j.1745-7254.2005.00134.x

 
Review
[ Full text ]
 
Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias1
 

De-zai DAI2, Feng YU

Research Division of Pharmacology, China Pharmaceutical University, Nanjing 210009, China

 

The occurrence of cardiac arrhythmias is related to the abnormality of ion channels not only in sarcolemma but also in the sarcoplasmic reticulum, which regulates the process of calcium release and up-take intracellularly. Patterns of ion channelopathy in the sarcolemma can be divided into single channel disorder from gene mutations and multiple channels disorder in a diseased hypertrophied heart. Abnormal RyR2, FKBP12.6, SERCA2a, and PLB are also involved in the initiation of cardiac arrhythmias. Maladjustment by hyperphosphorylation on the ion channels in the sarcolemma and RyR2-FKBP12.6 and SERCA2a-PLB is discussed. Hyperphosphorylation, which is the main abnormality upstream to ion channels, can be targeted for suppressing the deterioration of ion channelopathy in terms of new drug discovery in the treatment and prevention of malignant cardiac arrhythmias.

 

Keywords: ion channels; arrhythmia; ryanodine receptor calcium release channel; FKBP12.6; sarco-plasmic reticulum; phospholamban; phos-phorylation

 

1 Project supported by the National Natural Science Foundation of China (No 30230170).
2 Correspondence to Prof De-zai DAI.
Phn 86-25-8327-1270. Fax 86-25-8330-2827.
E-mail dezaidai@vip.sina.com
Received 2005-01-03     Accepted 2005-03-29

[ Full text ]
 

Copyright©APS 2009
Add: 294 Tai-Yuan Road, Shanghai 200031, China
Phn: 86-21-5492-2821  Fax: 86-21-5492-2823
E-mail: aps@mail.shcnc.ac.cn